Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 8/2016

28.01.2016 | Original Article

Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of 11C-l-methionine positron emission tomography

verfasst von: Mats Ryttlefors, Torsten Danfors, Francesco Latini, Anders Montelius, Erik Blomquist, Olafur Gudjonsson

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine if 11C-l-methionine PET is a useful tool in the evaluation of the long-term effect of proton beam treatment in patients with meningioma remnant.

Methods

Included in the study were 19 patients (4 men, 15 women) with intracranial meningioma remnants who received hypofractionated high-energy proton beam treatment. Patients were examined with 11C-l-methionine PET and MRI prior to treatment and after 6 months, and 1, 2, 3, 5, 7 and 10 years. Temporal changes in methionine uptake ratio, meningioma volume, meningioma regrowth and clinical symptoms throughout the follow-up period were evaluated.

Results

In 17 patients the tumour volume was unchanged throughout the follow-up. The methionine uptake ratio on PET decreased over the years in most patients. In two patients the tumour remnant showed progression on MRI. In these patients, prior to the volume increase on MRI, the methionine uptake ratio increased. One patient experienced transient clinical symptoms and showed radiological evidence of a radiation-induced reaction close to the irradiated field.

Conclusion

Proton beam treatment is a safe and effective treatment for achieving long-term growth arrest in meningioma remnants. Follow-up with 11C-l-methionine PET may be a valuable adjunct to, but not a replacement for, standard radiological follow-up.
Literatur
1.
Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus Jr RB, Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997;39:427–36.CrossRefPubMed
2.
Ichinose T, Goto T, Ishibashi K, Takami T, Ohata K. The role of radical microsurgical resection in multimodal treatment for skull base meningioma. J Neurosurg. 2010;113:1072–8.CrossRefPubMed
3.
Mathiesen T, Lindquist C, Kihlström L, Karlsson B. Recurrence of cranial base meningiomas. Neurosurgery. 1996;39:2–9.CrossRefPubMed
4.
DeMonte F, Smith HK, al-Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg. 1994;81:245–51.CrossRefPubMed
5.
6.
Abdel-Aziz KM, Froelich SC, Dagnew E, Jean W, Breneman JC, Zuccarello M, et al. Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes. Neurosurgery. 2004;54:1375–83. Discussion 1383–4.CrossRefPubMed
7.
Pichierri A, Santoro A, Raco A, Paolini S, Cantore G, Delfini R. Cavernous sinus meningiomas: retrospective analysis and proposal of a treatment algorithm. Neurosurgery. 2009;64:1090–101.CrossRefPubMed
8.
Misra BK. The paradigm of skull base meningiomas: what is optimal? World Neurosurg. 2012;78:220–1.CrossRefPubMed
9.
Bassiouni H, Asgari S, Sandalcioglu IE, Seifert V, Stolke D, Marquardt G. Anterior clinoidal meningiomas: functional outcome after microsurgical resection in a consecutive series of 106 patients. Clinical article. J Neurosurg. 2009;111:1078–90.CrossRefPubMed
10.
Seifert V. Clinical management of petroclival meningiomas and the eternal quest for preservation of quality of life: personal experiences over a period of 20 years. Acta Neurochir (Wien). 2010;152:1099–116.CrossRef
11.
O’Sullivan MG, van Loveren HR, Tew Jr JM. The surgical resectability of meningiomas of the cavernous sinus. Neurosurgery. 1997;40:238–44. Discussion 245–7.CrossRefPubMed
12.
De Monte F. Current management of meningiomas. Oncology (Williston Park). 1995;9:83–91, 96. Discussion 96, 99–101.
13.
Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg. 2010;113:1087–92.CrossRefPubMed
14.
McGregor JM, Sarkar A. Stereotactic radiosurgery and stereotactic radiotherapy in the treatment of skull base meningiomas. Otolaryngol Clin North Am. 2009;42:677–88.CrossRefPubMed
15.
Goldsmith B, Wara W, Wilson C, Larson D. Post-operative external beam irradiation for subtotally resected meningiomas. Int J Radiat Oncol Biol Phys. 1992;24:126–7.CrossRef
16.
Nutting C, Brada M, Brazil L, Sibtain A, Saran F, Westbury C, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg. 1999;90:823–7.CrossRefPubMed
17.
Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122:4–23.CrossRefPubMed
18.
Ohba S, Kobayashi M, Horiguchi T, Onozuka S, Yoshida K, Ohira T, et al. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas. J Neurosurg. 2011;114:1278–87.PubMed
19.
Tanzler E, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM. Outcomes of WHO grade I meningiomas receiving definitive or postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:508–13.CrossRefPubMed
20.
Duma CM, Lunsford LD, Kondziolka D, Harsh GRI, Flickinger JC. Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery. Neurosurgery. 1993;32:699–705.CrossRefPubMed
21.
Pollock BE, Stafford SL, Link MJ, Brown PD, Garces YI, Foote RL. Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery. 2012;71:604–13.CrossRefPubMed
22.
Starke RM, Williams BJ, Hiles C, Nguyen JH, Elsharkawy MY, Sheehan JP. Gamma knife surgery for skull base meningiomas. J Neurosurg. 2012;116:588–97.CrossRefPubMed
23.
Santacroce A, Walier M, Regis J, Liscak R, Motti E, Lindquist C, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012;70:32–9. Discussion 39.CrossRefPubMed
24.
Kimball MM, Friedman WA, Foote KD, Bova FJ, Chi Y-Y. Linear accelerator radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg. 2009;87:120–7.CrossRefPubMed
25.
dos Santos MA, de Salcedo JB, Gutierrez Diaz JA, Calvo FA, Samblas J, Marsiglia H, et al. Long-term outcomes of stereotactic radiosurgery for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2011;81:1436–41.CrossRefPubMed
26.
Haghighi N, Seely A, Paul E, Dally M. Hypofractionated stereotactic radiotherapy for benign intracranial tumours of the cavernous sinus. J Clin Neurosci. 2015;22:1450–5.CrossRefPubMed
27.
Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E, et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien). 1999;141:933–40.
28.
Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys. 2001;49:99–105.CrossRefPubMed
29.
Weber DC, Lomax AJ, Peter Rutz H, Stadelmann O, Egger E, Timmermann B, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol. 2004;71:251–8.CrossRefPubMed
30.
Slater JD, Loredo LN, Chung A, Bush DA, Patyal B, Johnson WD, et al. Fractionated proton radiotherapy for benign cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2012;83:e633–7.CrossRefPubMed
31.
Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1363–70.CrossRefPubMed
32.
Hug EB, DeVries A, Thornton AF, Munzenrider JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000;48:151–60.CrossRefPubMed
33.
Noël G, Habrand J-L, Mammar H, Haie-Meder C, Pontvert D, Dederke S, et al. Highly conformal therapy using proton component in the management of meningiomas. Strahlenther Onkol. 2002;178:480–5.CrossRefPubMed
34.
Noël G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys. 2005;62:1412–22.CrossRefPubMed
35.
Boskos C, Feuvret L, Noel G, Habrand J-L, Pommier P, Alapetite C, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys. 2009;75:399–406.CrossRefPubMed
36.
37.
Adegbite AB, Khan MI, Paine KWE, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg. 1983;58:51–6.CrossRefPubMed
38.
Jääskeläinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol. 1986;26:461–9.CrossRefPubMed
39.
40.
Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F. Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol. 2004;71:85–90.CrossRefPubMed
41.
Yamashita J, Handa H, Iwaki K, Abe M. Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol. 1980;14:33–40.PubMed
42.
Marks SM, Whitwell HL, Lye RH. Recurrence of meningiomas after operation. Surg Neurol. 1986;25:436–40.CrossRefPubMed
43.
Gudjonsson O, Blomquist E, Lilja A, Ericson H, Bergstrom M, Nyberg G. Evaluation of the effect of high-energy proton irradiation treatment on meningiomas by means of 11C-L-methionine PET. Eur J Nucl Med. 2000;27:1793–9.CrossRefPubMed
44.
45.
Cornelius JF, Langen KJ, Stoffels G, Hanggi D, Sabel M, Jakob SH. Positron emission tomography imaging of meningioma in clinical practice: review of literature and future directions. Neurosurgery. 2012;70:1033–41. Discussion 1042.CrossRefPubMed
46.
Iuchi T, Iwadate Y, Namba H, Osato K, Saeki N, Yamaura A, et al. Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res. 1999;21:640–4.PubMed
47.
Arita H, Kinoshita M, Okita Y, Hirayama R, Watabe T, Ishohashi K, et al. Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography. J Neurooncol. 2012;107:379–86.CrossRefPubMed
48.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system, 4th ed. Lyon: IARC; 2007.
49.
Grusell E, Montelius A, Russell KR, Blomquist E, Pellettieri L, Lilja A, et al. Patient positioning for fractionated precision radiation treatment of targets in the head using fiducial markers. Radiother Oncol. 1994;33:68–72.CrossRefPubMed
50.
Russell KR, Isacsson U, Saxner M, Ahnesjo A, Montelius A, Grusell E, et al. Implementation of pencil kernel and depth penetration algorithms for treatment planning of proton beams. Phys Med Biol. 2000;45:9–27.CrossRefPubMed
51.
ICRU. Prescribing, recording and reporting photon beam therapy (report 50). Bethesda: International Commission on Radiation Units and Measurements; 1993.
52.
Time, Dose and Fractionation in Radiotherapy. In: Hall EJ, Giaccia AJ, editors. Radiobiology for the radiologist. Philadelphia: Lippincott and Williams; 2012.
53.
Alvernia JE, Sindou MP. Preoperative neuroimaging findings as a predictor of the surgical plane of cleavage: prospective study of 100 consecutive cases of intracranial meningioma. J Neurosurg. 2004;100:422–30.CrossRefPubMed
54.
Simis A, de Aguiar PH P, Leite CC, Santana Jr PA, Rosemberg S, Teixeira MJ. Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol. 2008;70:471–7. Discussion 477.CrossRefPubMed
55.
Lee JW, Kang KW, Park SH, Lee SM, Paeng JC, Chung JK, et al. 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging. 2009;36:1574–82.CrossRefPubMed
56.
Lippitz B, Cremerius U, Mayfrank L, Bertalanffy H, Raoofi R, Weis J, et al. PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate. Acta Neurochir Suppl. 1996;65:108–11.PubMed
57.
Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10:437–44.CrossRefPubMed
58.
Bosnjak R, Derham C, Popovic M, Ravnik J. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J Neurosurg. 2005;103:473–84.CrossRefPubMed
59.
Martinez-Lage JF, Poza M, Martinez M, Esteban JA, Antunez MC, Sola J. Meningiomas with haemorrhagic onset. Acta Neurochir (Wien). 1991;110:129–32.CrossRef
60.
Kwon Y, Ahn JS, Jeon SR, Kim JH, Kim CJ, Lee JK, et al. Intratumoral bleeding in meningioma after gamma knife radiosurgery. J Neurosurg. 2002;97:657–62.PubMed
61.
Mangubat EZ, Byrne RW. Major intratumoral hemorrhage of a petroclival atypical meningioma: case report and review of literature. Skull Base. 2010;20:469–74.CrossRefPubMedPubMedCentral
62.
Navarria P, Pessina F, Cozzi L, Clerici E, Villa E, Ascolese AM, et al. Hypofractionated stereotactic radiation therapy in skull base meningiomas. J Neurooncol. 2015;124:283–9.CrossRefPubMed
Metadaten
Titel
Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of 11C-l-methionine positron emission tomography
verfasst von
Mats Ryttlefors
Torsten Danfors
Francesco Latini
Anders Montelius
Erik Blomquist
Olafur Gudjonsson
Publikationsdatum
28.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3310-z

Weitere Artikel der Ausgabe 8/2016

European Journal of Nuclear Medicine and Molecular Imaging 8/2016 Zur Ausgabe

Original Article

Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system

Book Review

Riemer H.J.A.Slart, René A.Tio, Philip H.Elsinga, Markus Schwaiger (Eds): Autonomic Innervation of the Heart: Role of Molecular Imaging

Image of the Month

Recurrent prosthetic mitral valve infective endocarditis and perivalvular abscess: first description by PET/CT angiography

Original Article

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

Original Article

Uncontrolled risk factors and worsening perfusion pattern on SPECT myocardial perfusion imaging in medically treated patients with stable chronic ischaemic heart disease

Book Review

Book Review on: Radioguided Surgery: Current Applications and Innovative Directions in Clinical Practice. Ken Hermann, Omgo E. Neiweg and Stephen P. Povoski (eds). Springer, Heidelberg, Germany